How pharmacokinetic and pharmacodynamic drug monitoring can improve outcome in solid organ transplant recipients

Author： Klupp J.   Holt D.W.   van Gelder T.  

Publisher： Elsevier

ISSN： 0966-3274

Source： Transplant Immunology, Vol.9, Iss.2, 2002-05, pp. : 211-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mycobacterial infections in solid organ transplant recipients

By Arslan H.   Eyuboglu F.O..   Kalpaklioglu F.   Gurdogan K.   Akcay S.   Demirag A.   Haberal M.  

Transplantation Proceedings, Vol. 31, Iss. 8, 1999-12 ,pp. : 3197-3198

Elsevier

Access to resources Recommend Favorite

Cytomegalovirus prophylaxis in solid organ transplant recipients: the issues

By Legendre C.   Thervet E.  

Transplantation Proceedings, Vol. 32, Iss. 2, 2000-03 ,pp. : 377-378

Elsevier

Access to resources Recommend Favorite

Percutaneous dilational tracheotomy in solid-organ transplant recipients

By Pirat A.   Zeyneloglu P.   Candan S.   Akkuzu B.   Arslan G.  

Transplantation Proceedings, Vol. 36, Iss. 1, 2004-01 ,pp. : 221-223

Elsevier

Access to resources Recommend Favorite

De novo sarcomas in solid organ transplant recipients

By Husted T.L.   Buell J.F.   Hanaway M.J.   Trofe J.   Beebe T.   Gross T.   First M.R.   Woodle E.S.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1786-1787

Elsevier

Access to resources Recommend Favorite

Tuberculosis in organ transplant recipients

By Chugh K.S.   Jha V.  

Transplantation Proceedings, Vol. 35, Iss. 7, 2003-11 ,pp. : 2676-2677

Elsevier

Access to resources Recommend Favorite